Omeros Corporation Gains 50.88%
Mon, Aug 10, 2020 at 05:34 PM
Omeros Corporation (OMER:NASDAQ) rocketted at $21.32, representing a gain of 50.9%. On Fri 07 Aug 20, OMER:NASDAQ touched a New 2-Week High of $14.13. The stock appeared on our News Catalysts scanner on Mon 10 Aug 20 at 04:32 PM in the 'PUBLIC OFFERING' category. From Fri 24 Jul 20, the stock recorded 50.00% Up Days and 54.55% Green Days
The stock spiked on Thu 05 Mar 20 at $20.6 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About Omeros Corporation (OMER:NASDAQ)
Omeros Corp is a biopharmaceutical company. It focuses on research and development of small-molecule and protein therapeutics to treat inflammation, coagulopathies, and disorders of the central nervous system and sells Omidria for cataract surgeries.
Top 10 Gainers:
- Seres Therapeutics, Inc. (MCRB:NASDAQ), 389.22%
- Omeros Corporation (OMER:NASDAQ), 50.88%
- BiomX Inc. (PHGE:NYSEMKT), 42.1%
- Commercial Vehicle Group, Inc. (CVGI:NASDAQ), 37.04%
- Xtant Medical Holdings, Inc. (XTNT:NYSEMKT), 32.43%
- Adamas Pharmaceuticals, Inc. (ADMS:NASDAQ), 31.75%
- Trevena, Inc. (TRVN:NASDAQ), 31.51%
- Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 30.51%
- LSB Industries, Inc. (LXU:NYSE), 29.75%
- Ocugen, Inc. (OCGN:NASDAQ), 28.18%